Active Pharmaceutical Ingredients Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

Active Pharmaceutical Ingredients Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

Active Pharmaceutical Ingredients (API) are active constituents used in the manufacturing of pharmaceutical formulations and have pharmacological and therapeutic effects on the body. Since APIs cannot be used in the raw form, they are combined with the suitable excipients, which are pharmacologically and therapeutically inactive but enhance its stability and activities.

Market Dynamics

Increasing prevalence of chronic diseases, geographical expansion of active pharmaceutical ingredient manufacturers in Asia, and increasing investment in research and development by manufacturers are some of the major factors that are expected to drive the market growth. Furthermore, increasing production of generic drugs is in turn driving growth of global active pharmaceutical ingredients market. For instance, according to the Indian Brand Equity Foundation (IBEF), in 2018, India was the largest producer of generic medicines, which supplied 50% of vaccines and 40% of drugs to the U.S. and 25% of drugs to the U.K. However, unfavorable drug price control policies across various countries is expected to negatively affect growth of the market.

Key features of the study:

• This report provides in-depth analysis of the active pharmaceutical ingredients market and provides market size (US$ Bn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global active pharmaceutical ingredients market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Pfizer, Inc., BASF SE, Dr. Reddy’s Laboratories Ltd., Novartis AG, Mylan N.V., Sanofi S.A., and Lonza
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global active pharmaceutical ingredients market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the active pharmaceutical ingredients market

Detailed Segmentation:

• Global Active Pharmaceutical Ingredients Market, By API:
• Branded/ Innovative
• Generic
• Global Active Pharmaceutical Ingredients Market, By Type of Synthesis:
• Synthetic
• Biotech
• Global Active Pharmaceutical Ingredients Market, By Application:
• Diabetes
• Oncology
• Cardiovascular
• CNS
• Analgesics
• Others
• Global Active Pharmaceutical Ingredients Market, By Region:
• North America
• By API:
• Branded/ Innovative
• Generic
• By Type of Synthesis:
• Synthetic
• Biotech
• By Application:
• Diabetes
• Oncology
• Cardiovascular
• CNS
• Analgesics
• Others
• By Country:
• U.S.
• Canada
• Latin America
• By API:
• Branded/ Innovative
• Generic
• By Type of Synthesis:
• Synthetic
• Biotech
• By Application:
• Diabetes
• Oncology
• Cardiovascular
• CNS
• Analgesics
• Others
• By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By API:
• Branded/ Innovative
• Generic
• By Type of Synthesis:
• Synthetic
• Biotech
• By Application:
• Diabetes
• Oncology
• Cardiovascular
• CNS
• Analgesics
• Others
• By Country:
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By API:
• Branded/ Innovative
• Generic
• By Type of Synthesis:
• Synthetic
• Biotech
• By Application:
• Diabetes
• Oncology
• Cardiovascular
• CNS
• Analgesics
• Others
• By Country:
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By API:
• Branded/ Innovative
• Generic
• By Type of Synthesis:
• Synthetic
• Biotech
• By Application:
• Diabetes
• Oncology
• Cardiovascular
• CNS
• Analgesics
• Others
• By Country:
• GCC
• Israel
• Rest of Middle East
• Africa
• By API:
• Branded/ Innovative
• Generic
• By Type of Synthesis:
• Synthetic
• Biotech
• By Application:
• Diabetes
• Oncology
• Cardiovascular
• CNS
• Analgesics
• Others
• By Country:
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Teva Pharmaceutical Industries Ltd.*
• Company Overview
• Material Portfolio
• Financial Performance
• Key Highlights
• Market Strategies
• Pfizer, Inc.
• BASF SE
• Dr. Reddy’s Laboratories Ltd.
• Novartis AG
• Mylan N.V.
• Sanofi S.A.
• Lonza

“*” marked represents similar segmentation in other categories in the respective section.